GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (XBUL:NVV1) » Definitions » E10

Novavax (XBUL:NVV1) E10 : лв-13.01 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Novavax E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novavax's adjusted earnings per share data for the three months ended in Dec. 2024 was лв-0.919. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is лв-13.01 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was -2.10% per year. During the past 5 years, the average E10 Growth Rate was -7.80% per year. During the past 10 years, the average E10 Growth Rate was -5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novavax was 11.20% per year. The lowest was -12.00% per year. And the median was -2.10% per year.

As of today (2025-03-24), Novavax's current stock price is лв7.281. Novavax's E10 for the quarter that ended in Dec. 2024 was лв-13.01. Novavax's Shiller PE Ratio of today is .


Novavax E10 Historical Data

The historical data trend for Novavax's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax E10 Chart

Novavax Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -13.01

Novavax Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -14.03 -10.41 -13.01

Competitive Comparison of Novavax's E10

For the Biotechnology subindustry, Novavax's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novavax's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novavax's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novavax's Shiller PE Ratio falls into.



Novavax E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novavax's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.919/133.1571*133.1571
=-0.919

Current CPI (Dec. 2024) = 133.1571.

Novavax Quarterly Data

per share eps CPI Adj_EPS
201503 -3.605 99.621 -4.819
201506 -2.884 100.684 -3.814
201509 -4.326 100.392 -5.738
201512 -10.456 99.792 -13.952
201603 -10.456 100.470 -13.858
201606 -10.456 101.688 -13.692
201609 -8.653 101.861 -11.312
201612 -7.571 101.863 -9.897
201703 -5.769 102.862 -7.468
201706 -5.769 103.349 -7.433
201709 -5.425 104.136 -6.937
201712 -5.769 104.011 -7.386
201803 -5.048 105.290 -6.384
201806 -4.272 106.317 -5.350
201809 -4.200 106.507 -5.251
201812 -4.687 105.998 -5.888
201903 -3.804 107.251 -4.723
201906 -3.047 108.070 -3.754
201909 -1.334 108.329 -1.640
201912 -2.037 108.420 -2.502
202003 -1.046 108.902 -1.279
202006 -0.541 108.767 -0.662
202009 -5.787 109.815 -7.017
202012 -4.867 109.897 -5.897
202103 -5.498 111.754 -6.551
202106 -8.563 114.631 -9.947
202109 -7.770 115.734 -8.940
202112 -20.154 117.630 -22.814
202203 4.615 121.301 5.066
202206 -11.772 125.017 -12.539
202209 -3.876 125.227 -4.121
202212 -4.110 125.222 -4.370
202303 -6.147 127.348 -6.427
202306 1.046 128.729 1.082
202309 -2.271 129.860 -2.329
202312 -2.650 129.419 -2.727
202403 -1.893 131.776 -1.913
202406 1.785 132.554 1.793
202409 -1.370 133.029 -1.371
202412 -0.919 133.157 -0.919

Add all the adjusted EPS together and divide 10 will get our e10.


Novavax  (XBUL:NVV1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novavax E10 Related Terms

Thank you for viewing the detailed overview of Novavax's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Novavax Business Description

Address
700 Quince Orchard Road, Gaithersburg, MD, USA, 20878
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Novavax Headlines

No Headlines